Earlier this year, Medtronic began a worldwide pivotal study evaluating its investigational Extravascular Implantable Cardioverter Defibrillator (EV ICD) system to treat dangerously fast heart rhythms. The EV ICD system is designed to deliver lifesaving defibrillation and pacing therapy via a device the same size as traditional, transvenous ICDs, but with a lead (thin wire) placed outside the heart and veins. The future of CRM device technology.
Feature | EP Lab | Hrishikesh Kadam
The Future of Cardiac Rhythm Management Device Technology

Cardiac rhythm management (CRM) devices in use today are evolving to raise the bar beyond monitoring and managing ...

Home November 11, 2019
Home
Siemens Healthineers Acquires ECG Management Consultants
News | Cardiovascular Business
Siemens Healthineers Acquires ECG Management Consultants

November 11, 2019 — ECG Management Consultants, a leading U.S. healthcare advisory firm, is now part of the global ...

Home November 11, 2019
Home
Indigo System CAT RX Aspiration Catheter and Penumbra Engine
News
Indigo Aspiration System IDE Trial for Acute Pulmonary Embolism Meets Primary Safety and Efficacy

November 8, 2019 — Penumbra Inc. announced that the EXTRACT-PE trial successfully met the primary endpoints ...

Home November 08, 2019
Home
Intact Vascular Tack
News
Endovascular Tacking System Safe for Dissections in the TOBA II BTK Study

November 8, 2019 — Dissection is a frequent and clinically problematic outcome of percutaneous transluminal balloon ...

Home November 08, 2019
Home
Bioresorbable stent Abbott Absorb stent
News
One-Year Results of the DISAPEAR Registry Positive for Absorb Stent

November 8, 2019 — The Absorb bioresorbable stent (BVS) demonstrated good patency and clinical outcomes in patients with ...

Home November 08, 2019
Home
Videos | Nuclear Imaging
VIDEO: Better Flow Quantification and Rise of PET Among Trends in Cardiac Nuclear Imaging

American Society of Nuclear Cardiology (ASNC) President Rob Beanlands, M.D., shares a couple trends he sees in cardiac nuclear imaging.

Home November 07, 2019
Home
Videos | Artificial Intelligence
VIDEO: Machine Learning for Diagnosis and Risk Prediction in Nuclear Cardiology

Piotr Slomka explains how his team at Cedars-Sinai is working on intelligent patient risk prediction algorithms...

Home November 07, 2019
Home
The Saranas Early Bird Bleed Monitoring System offers real-time detection and monitoring of transcatheter intervention vascular access site bleed complications.
News | Vascular Access
Early Bird Bleed Monitoring System Used in First Commercial U.S. Patient

November 6, 2019 — Saranas Inc. announced completion of the first U.S. commercial case using its Early Bird Bleed ...

Home November 07, 2019
Home
News | Stents Bioresorbable
Bioresorbable Stent Shows Good 5-Year Outcomes in ABSORB BTK Trial

November 7, 2019 — Although the Abbott Absorb fully bioresorbable drug-eluting stent (DES) was taken off the market due ...

Home November 07, 2019
Home
In.Pact Admiral drug-coated balloon (DCB). #VIVA #VIVA19 #VIVA2019
News | Drug-Eluting Balloons
Drug-coated Balloon Maintains Good Outcomes in 4-Year IN.PACT Global Study Data

November 7, 2019 — Real-world, four-year study results of the In.Pact Admiral drug-coated balloon (DCB) demonstrate long ...

Home November 07, 2019
Home
The AngioDynamics/Eximo Medical B-Laser represents a new atherectomy device. #VIVA2019 #VIVA #VIVA19
News | Atherectomy Devices
No Difference Between Drug-coated Balloons and Plain Balloons After Laser Atherectomy

November 7, 2019 — There was no difference between drug-coated balloons (DCB) vs. plain old balloon angioplasty (POBA) ...

Home November 07, 2019
Home
One of the cardiology technologies in the list of top advances in 2019 is Medtronic’s Tyrx Absorbable Antibacterial Envelope using to enclose cardiac implantable electronic devices (CIEDs). It reduced the risk of major infection by 40 percent, and pocket infection by 61 percent, based on data presented at ACC 2019.
News
Cleveland Clinic Unveils Top 10 Medical Innovations for 2020

November 6, 2019 — Cleveland Clinic announced the Top 10 Medical Innovations for 2020 at a multimedia presentation last ...

Home November 06, 2019
Home
Videos | Nuclear Imaging
VIDEO: New Cardiac Radiotracers in Development

Doctor Robert Hendel explains some of the new cardiac radiotracers in the pipeline that were discussed in sessions at the American Society of Nuclear Cardiology (ASNC) 2019 meeting...

Home November 06, 2019
Home
Edwards Sapien 3 TAVI Granted European Approval to Treat Low-risk Patients. TAVR cleared for low risk patients in Europe
Feature
Edwards Sapien 3 TAVI Granted European Approval to Treat Low-risk Patients

November 6, 2019 — Edwards Lifesciences announced it received European CE mark to expand use of the Edwards Sapien 3 ...

Home November 06, 2019
Home
The final, long-term, patient-level data for the Cook Medical Zilver PTX drug-eluting stent (DES) were evaluated to determine if there is an increased mortality risk due to paclitaxel, but was no difference was seen in the five-year mortality rates compared to control patients. #VIVA19 #VIVA #VIVA2019
Feature | Stents Peripheral | Dave Fornell, Editor
No Increased Long-Term Mortality for the Paclitaxel-Coated Zilver PTX Stent

November 6, 2019 – The final, long-term, patient-level data for the Cook Medical Zilver PTX drug-eluting stent (DES) ...

Home November 06, 2019
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now